Amyloid heart disease is under-recognized. Early detection and prompt initiation of therapy are critically important. With advances in imaging technology, the diagnosis or surveillance of cardiac ...

The U.S. Food and Drug Administration (FDA) has approved a groundbreaking drug, acoramidis (marketed as Attruby), developed ...

This is due to how AL amyloidosis affects vital organs, particularly the heart. AL amyloidosis may have a greater impact on the outlook for people with smoldering MM than symptomatic MM.

NFL Hall of Famer Art Still advocates for awareness of amyloidosis, a rare disease affecting 1 in 25 African Americans. Learn more about the disease and its impact.

Newer therapies for multiple conditions were major stories this year, but long-term HF survival gains seem to have vanished.

But these proteins have an impact on more than the heart. They travel to other places in the body, as well, she says. Amyloid buildup can affect the gastrointestinal system, the peripheral nervous ...

The Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of acoramidis in the EU based on positive results from the ...

Endomyocardial biopsy is necessary to confirm cardiac amyloidosis in many cases. A rapid initial therapy mainly with diuretics is usually needed to stabilize patients with congestive heart failure.